178 related articles for article (PubMed ID: 37716620)
1. Interplay between Estrogen, Kynurenine, and AHR Pathways: An immunosuppressive axis with therapeutic potential for breast cancer treatment.
Pacheco JHL; Elizondo G
Biochem Pharmacol; 2023 Nov; 217():115804. PubMed ID: 37716620
[TBL] [Abstract][Full Text] [Related]
2. Reimagining IDO Pathway Inhibition in Cancer Immunotherapy via Downstream Focus on the Tryptophan-Kynurenine-Aryl Hydrocarbon Axis.
Labadie BW; Bao R; Luke JJ
Clin Cancer Res; 2019 Mar; 25(5):1462-1471. PubMed ID: 30377198
[TBL] [Abstract][Full Text] [Related]
3. Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine.
Campesato LF; Budhu S; Tchaicha J; Weng CH; Gigoux M; Cohen IJ; Redmond D; Mangarin L; Pourpe S; Liu C; Zappasodi R; Zamarin D; Cavanaugh J; Castro AC; Manfredi MG; McGovern K; Merghoub T; Wolchok JD
Nat Commun; 2020 Aug; 11(1):4011. PubMed ID: 32782249
[TBL] [Abstract][Full Text] [Related]
4. Increased kynurenine concentration attenuates serotonergic neurotoxicity induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats through activation of aryl hydrocarbon receptor.
Abuin-Martínez C; Vidal R; Gutiérrez-López MD; Pérez-Hernández M; Giménez-Gómez P; Morales-Puerto N; O'Shea E; Colado MI
Neuropharmacology; 2021 Apr; 187():108490. PubMed ID: 33607146
[TBL] [Abstract][Full Text] [Related]
5. An Aryl Hydrocarbon Receptor-Mediated Amplification Loop That Enforces Cell Migration in ER-/PR-/Her2- Human Breast Cancer Cells.
Novikov O; Wang Z; Stanford EA; Parks AJ; Ramirez-Cardenas A; Landesman E; Laklouk I; Sarita-Reyes C; Gusenleitner D; Li A; Monti S; Manteiga S; Lee K; Sherr DH
Mol Pharmacol; 2016 Nov; 90(5):674-688. PubMed ID: 27573671
[TBL] [Abstract][Full Text] [Related]
6. Blockade of IDO-Kynurenine-AhR Axis Ameliorated Colitis-Associated Colon Cancer via Inhibiting Immune Tolerance.
Zhang X; Liu X; Zhou W; Du Q; Yang M; Ding Y; Hu R
Cell Mol Gastroenterol Hepatol; 2021; 12(4):1179-1199. PubMed ID: 34087454
[TBL] [Abstract][Full Text] [Related]
7. Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn-AhR-AQP4 signaling pathway.
Du L; Xing Z; Tao B; Li T; Yang D; Li W; Zheng Y; Kuang C; Yang Q
Signal Transduct Target Ther; 2020 Feb; 5(1):10. PubMed ID: 32296044
[TBL] [Abstract][Full Text] [Related]
8. The aryl hydrocarbon receptor (AhR) mediates resistance to apoptosis induced in breast cancer cells.
Bekki K; Vogel H; Li W; Ito T; Sweeney C; Haarmann-Stemmann T; Matsumura F; Vogel CF
Pestic Biochem Physiol; 2015 May; 120():5-13. PubMed ID: 25987214
[TBL] [Abstract][Full Text] [Related]
9. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor.
Opitz CA; Litzenburger UM; Sahm F; Ott M; Tritschler I; Trump S; Schumacher T; Jestaedt L; Schrenk D; Weller M; Jugold M; Guillemin GJ; Miller CL; Lutz C; Radlwimmer B; Lehmann I; von Deimling A; Wick W; Platten M
Nature; 2011 Oct; 478(7368):197-203. PubMed ID: 21976023
[TBL] [Abstract][Full Text] [Related]
10. Kynurenine produced by indoleamine 2,3-dioxygenase 2 exacerbates acute liver injury by carbon tetrachloride in mice.
Hoshi M; Osawa Y; Nakamoto K; Morita N; Yamamoto Y; Ando T; Tashita C; Nabeshima T; Saito K
Toxicology; 2020 May; 438():152458. PubMed ID: 32289347
[TBL] [Abstract][Full Text] [Related]
11. Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytes.
Solvay M; Holfelder P; Klaessens S; Pilotte L; Stroobant V; Lamy J; Naulaerts S; Spillier Q; Frédérick R; De Plaen E; Sers C; Opitz CA; Van den Eynde BJ; Zhu J
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37344101
[TBL] [Abstract][Full Text] [Related]
12. Indoleamine 2,3-Dioxygenase Activity-Induced Acceleration of Tumor Growth, and Protein Kinases-Related Novel Therapeutics Regimens.
Engin AB; Engin A
Adv Exp Med Biol; 2021; 1275():339-356. PubMed ID: 33539022
[TBL] [Abstract][Full Text] [Related]
13. Activation of aryl hydrocarbon receptor (AhR) in Alzheimer's disease: role of tryptophan metabolites generated by gut host-microbiota.
Salminen A
J Mol Med (Berl); 2023 Mar; 101(3):201-222. PubMed ID: 36757399
[TBL] [Abstract][Full Text] [Related]
14. Adipocyte-derived kynurenine stimulates malignant transformation of mammary epithelial cells through the aryl hydrocarbon receptor.
Diedrich JD; Gonzalez-Pons R; Medeiros HCD; Ensink E; Liby KT; Wellberg EA; Lunt SY; Bernard JJ
Biochem Pharmacol; 2023 Oct; 216():115763. PubMed ID: 37625554
[TBL] [Abstract][Full Text] [Related]
15. Kynurenine, a Tryptophan Metabolite That Increases with Age, Induces Muscle Atrophy and Lipid Peroxidation.
Kaiser H; Yu K; Pandya C; Mendhe B; Isales CM; McGee-Lawrence ME; Johnson M; Fulzele S; Hamrick MW
Oxid Med Cell Longev; 2019; 2019():9894238. PubMed ID: 31737181
[TBL] [Abstract][Full Text] [Related]
16. Investigation of the aryl hydrocarbon receptor and the intrinsic tumoral component of the kynurenine pathway of tryptophan metabolism in primary brain tumors.
Guastella AR; Michelhaugh SK; Klinger NV; Fadel HA; Kiousis S; Ali-Fehmi R; Kupsky WJ; Juhász C; Mittal S
J Neurooncol; 2018 Sep; 139(2):239-249. PubMed ID: 29667084
[TBL] [Abstract][Full Text] [Related]
17. The kynurenine pathway in brain tumor pathogenesis.
Adams S; Braidy N; Bessede A; Brew BJ; Grant R; Teo C; Guillemin GJ
Cancer Res; 2012 Nov; 72(22):5649-57. PubMed ID: 23144293
[TBL] [Abstract][Full Text] [Related]
18. Kynurenine Is the Main Metabolite of Tryptophan Degradation by Tryptophan 2,3-Dioxygenase in HepG2 Tumor Cells.
Oweira H; Lahdou I; Mehrle S; Khajeh E; Nikbakhsh R; Ghamarnejad O; Terness P; Reißfelder C; Sadeghi M; Ramouz A
J Clin Med; 2022 Aug; 11(16):. PubMed ID: 36013032
[TBL] [Abstract][Full Text] [Related]
19. Associations of microbial and indoleamine-2,3-dioxygenase-derived tryptophan metabolites with immune activation in healthy adults.
Riazati N; Kable ME; Newman JW; Adkins Y; Freytag T; Jiang X; Stephensen CB
Front Immunol; 2022; 13():917966. PubMed ID: 36248784
[TBL] [Abstract][Full Text] [Related]
20. Kynurenine emerges from the shadows - Current knowledge on its fate and function.
Marszalek-Grabska M; Walczak K; Gawel K; Wicha-Komsta K; Wnorowska S; Wnorowski A; Turski WA
Pharmacol Ther; 2021 Sep; 225():107845. PubMed ID: 33831481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
